Skip to content

Emilija Glavonic

5 papers in the library · 25 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Comparable Acute Antidepressant-like Effects of Two Subanesthetic Ketamine Doses Are Associated with Divergent Region-Specific Molecular Responses After Adolescent Chronic Stress

International Journal of Molecular Sciences October 15, 2026 Ana Zivanovic, Iva Lukic, Emilija Glavonic et al.

Ketamine produces rapid antidepressant-like effects across a range of subanesthetic doses, yet how dose shapes behavioral efficacy and region-specific molecular signaling following adolescent chronic unpredictable stress (CUS) is not well understood. Here, we examined the behavioral and molecular consequences of two subanesthetic ketamine doses in adult mice with depression-like behavior...

Kappa-Opioid Receptor Antagonism Prolongs the Antidepressant Effects of Ketamine in Adult Mice with Depression-like Behavior Induced by Adolescent Chronic Unpredictable Stress

International Journal of Molecular Sciences March 20, 2026 Ana Zivanovic, Milos Mitic, Iva Lukic et al.

Major depressive disorder (MDD) is a highly prevalent psychiatric illness for which rapid-acting antidepressants such as ketamine provide only transient benefit. Because κ-opioid receptor (KOR) signaling contributes to stress-related dysphoria and impaired neuroplasticity, we examined whether KOR antagonism could prolong ketamine’s antidepressant-like effects in a mouse model of adolescent...

Ketamine's Amelioration of Fear Extinction in Adolescent Male Mice Is Associated with the Activation of the Hippocampal Akt-mTOR-GluA1 Pathway.

Pharmaceuticals May 22, 2024 Emilija Glavonic, Milorad Dragic, Milos Mitic et al. 5 citations

Fear-related disorders, including post-traumatic stress disorder (PTSD), and anxiety disorders are pervasive psychiatric conditions marked by persistent fear, stemming from its dysregulated acquisition and extinction. The primary treatment for these disorders, exposure therapy (ET), relies heavily on fear extinction (FE) principles. Adolescence, a vulnerable period for developing psychiatric...

DOI: 10.3390/ph17060669 (opens in new tab) Full text (opens in new tab) Ketamine Adolescence Fear extinction Fear-related disorders +7

Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine.

Life Science May 1, 2023 Miroslav Adzic, Iva Lukic, Milos Mitic et al.

Major depressive disorder (MDD) afflicts approximately 5 % of the world population, and about 30-50 % of patients who receive classical antidepressant medications do not achieve complete remission (treatment resistant depressive patients). Emerging evidence suggests that targeting opioid receptors mu (MOP), kappa (KOP), delta (DOP), and the nociceptin/orphanin FQ receptor (NOP) may yield...

Hallucinogenic drugs and their potential for treating fear-related disorders: Through the lens of fear extinction.

Journal of Neuroscience Research April 1, 2022 Emilija Glavonic, Milos Mitic, Miroslav Adzic 20 citations

Fear-related disorders, mainly phobias and post-traumatic stress disorder, are highly prevalent, debilitating disorders that pose a significant public health problem. They are characterized by aberrant processing of aversive experiences and dysregulated fear extinction, leading to excessive expression of fear and diminished quality of life. The gold standard for treating fear-related disorders...